Correlation analysis of invasive disease-free survival and overall survival in a real-world population of patients with HR+/HER2- early breast cancer.
Saved in:
| Title: | Correlation analysis of invasive disease-free survival and overall survival in a real-world population of patients with HR+/HER2- early breast cancer. |
|---|---|
| Authors: | Graff SL; Brown University Health Cancer Institute, Legorreta Cancer Center at Brown University, Providence, Rhode Island, USA., Tolaney SM; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Hart LL; Florida Cancer Specialists, Sarah Cannon Research Institute, Fort Myers, Florida, USA.; Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA., Razavi P; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Janni W; Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany., Schwartzberg LS; Renown Health-William N. Pennington Cancer Institute, Reno, Nevada, USA., Danyliv A; Novartis Pharma AG, Basel, Switzerland., Akdere M; Novartis Pharma AG, Basel, Switzerland., Ferrusi I; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA., Adhikary RR; Novartis Healthcare Pvt., Ltd, Hyderabad, Telangana, India., O'Shaughnessy JA; Texas Oncology/Baylor University Medical Center, Dallas, Texas, USA. |
| Source: | Cancer [Cancer] 2025 Apr 01; Vol. 131 (7), pp. e35817. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40159245 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Correlation analysis of invasive disease-free survival and overall survival in a real-world population of patients with HR+/HER2- early breast cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Graff+SL%22">Graff SL</searchLink>; Brown University Health Cancer Institute, Legorreta Cancer Center at Brown University, Providence, Rhode Island, USA.<br /><searchLink fieldCode="AU" term="%22Tolaney+SM%22">Tolaney SM</searchLink>; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Hart+LL%22">Hart LL</searchLink>; Florida Cancer Specialists, Sarah Cannon Research Institute, Fort Myers, Florida, USA.; Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Razavi+P%22">Razavi P</searchLink>; Memorial Sloan Kettering Cancer Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Janni+W%22">Janni W</searchLink>; Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Schwartzberg+LS%22">Schwartzberg LS</searchLink>; Renown Health-William N. Pennington Cancer Institute, Reno, Nevada, USA.<br /><searchLink fieldCode="AU" term="%22Danyliv+A%22">Danyliv A</searchLink>; Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Akdere+M%22">Akdere M</searchLink>; Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Ferrusi+I%22">Ferrusi I</searchLink>; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Adhikary+RR%22">Adhikary RR</searchLink>; Novartis Healthcare Pvt., Ltd, Hyderabad, Telangana, India.<br /><searchLink fieldCode="AU" term="%22O'Shaughnessy+JA%22">O'Shaughnessy JA</searchLink>; Texas Oncology/Baylor University Medical Center, Dallas, Texas, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220374236%22">Cancer</searchLink> [Cancer] 2025 Apr 01; Vol. 131 (7), pp. e35817. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0374236 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-0142 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220008543X%22">0008543X </searchLink><i>NLM ISO Abbreviation: </i>Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40159245 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/cncr.35817 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e35817 Titles: – TitleFull: Correlation analysis of invasive disease-free survival and overall survival in a real-world population of patients with HR+/HER2- early breast cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Graff SL – PersonEntity: Name: NameFull: Tolaney SM – PersonEntity: Name: NameFull: Hart LL – PersonEntity: Name: NameFull: Razavi P – PersonEntity: Name: NameFull: Janni W – PersonEntity: Name: NameFull: Schwartzberg LS – PersonEntity: Name: NameFull: Danyliv A – PersonEntity: Name: NameFull: Akdere M – PersonEntity: Name: NameFull: Ferrusi I – PersonEntity: Name: NameFull: Adhikary RR – PersonEntity: Name: NameFull: O'Shaughnessy JA IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2025 Apr 01 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1097-0142 Numbering: – Type: volume Value: 131 – Type: issue Value: 7 Titles: – TitleFull: Cancer Type: main |
| ResultId | 1 |
